|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 31/4545 | (2006.01) |
| A61P 27/02 | (2006.01) | ||
| A61P 11/00 | (2006.01) | ||
| A61P 37/00 | (2006.01) |
| (11) | Number of the document | 2833884 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13713199.1 |
| Date of filing the European patent application | 2013-04-02 | |
| (97) | Date of publication of the European application | 2015-02-11 |
| (45) | Date of publication and mention of the grant of the patent | 2020-05-20 |
| (46) | Date of publication of the claims translation | 2020-09-10 |
| (86) | Number | PCT/EP2013/056864 |
| Date | 2013-04-02 |
| (87) | Number | WO 2013/149986 |
| Date | 2013-10-10 |
| (30) | Number | Date | Country code |
| 12162937 | 2012-04-03 | EP |
| (72) |
NIVENS, Michael Chadham, DE
BOUYSSOU, Thierry, DE
GOEGGEL, Rolf, DE
SEITHER, Peter, DE
|
| (73) |
Alkahest, Inc.,
125 Shoreway Road, Suite D, San Carlos, CA 94070,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | CCR3-inhibitorių panaudojimas |
| USE OF CCR3-INHIBITORS |
| Payment date | Validity (years) | Amount | |
| 2025-03-25 | 13 | 289.00 EUR |
| 2026-04-02 |